Shannon Thyme Klinger Moderna, Inc. (MRNA) insider trading activity

Shannon Thyme Klinger is Chief Legal Officer of Moderna, Inc.. Currently has a direct ownership of 53,231 shares of MRNA, which is worth approximately $1.32 Million. The most recent transaction as insider was on Dec 05, 2025, when has been sold 22,817 shares (Common Stock) at a price of $25.49 per share, resulting in proceeds of $581,605. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.2K

88.96% 3M change

160.35% 12M change

Total Value Held $1.32 Million

Shannon Thyme Klinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 05 2025	SELL Payment of exercise price or tax liability	$581,605 $25.49 p/Share	22,817 Reduced 30.0%	53,231 Common Stock
Dec 05 2025	BUY Exercise of conversion of derivative security	-	47,190 Added 38.29%	76,048 Common Stock
Dec 01 2025	SELL Payment of exercise price or tax liability	$2,935 $25.98 p/Share	113 Reduced 0.39%	28,858 Common Stock
Dec 01 2025	BUY Exercise of conversion of derivative security	-	233 Added 0.8%	28,971 Common Stock
Nov 28 2025	SELL Payment of exercise price or tax liability	$4,001 $25.01 p/Share	160 Reduced 0.55%	28,738 Common Stock
Nov 28 2025	BUY Exercise of conversion of derivative security	-	329 Added 1.13%	28,898 Common Stock
Nov 26 2025	SELL Payment of exercise price or tax liability	$9,256 $24.75 p/Share	374 Reduced 1.29%	28,569 Common Stock

Nov 26 2025	BUY Exercise of conversion of derivative security	-	773 Added 2.6%	28,943 Common Stock
Aug 29 2025	SELL Payment of exercise price or tax liability	$2,765 $24.47 p/Share	113 Reduced 0.4%	28,170 Common Stock
Aug 29 2025	BUY Exercise of conversion of derivative security	-	232 Added 0.81%	28,283 Common Stock
Aug 28 2025	SELL Payment of exercise price or tax liability	$4,016 $25.1 p/Share	160 Reduced 0.57%	28,051 Common Stock
Aug 28 2025	BUY Exercise of conversion of derivative security	-	329 Added 1.15%	28,211 Common Stock
Aug 27 2025	SELL Payment of exercise price or tax liability	$9,273 $24.73 p/Share	375 Reduced 1.33%	27,882 Common Stock
Aug 27 2025	BUY Exercise of conversion of derivative security	-	774 Added 2.67%	28,257 Common Stock
Jun 06 2025	SELL Payment of exercise price or tax liability	$14,392 $26.12 p/Share	551 Reduced 1.97%	27,483 Common Stock
Jun 06 2025	BUY Exercise of conversion of derivative security	-	1,139 Added 3.9%	28,034 Common Stock
May 30 2025	SELL Payment of exercise price or tax liability	$3,043 $26.93 p/Share	113 Reduced 0.43%	26,300 Common Stock
May 30 2025	BUY Exercise of conversion of derivative security	-	233 Added 0.87%	26,413 Common Stock
May 28 2025	SELL Payment of exercise price or tax liability	$4,254 $26.76 p/Share	159 Reduced 0.6%	26,180 Common Stock
May 28 2025	BUY Exercise of conversion of derivative security	-	328 Added 1.23%	26,339 Common Stock
May 27 2025	SELL Payment of exercise price or tax liability	$9,821 $26.26 p/Share	374 Reduced 1.42%	26,011 Common Stock
May 27 2025	BUY Exercise of conversion of derivative security	-	773 Added 2.85%	26,385 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$18,899 $34.3 p/Share	551 Reduced 2.11%	25,612 Common Stock
Mar 07 2025	BUY Exercise of conversion of derivative security	-	1,139 Added 4.17%	26,163 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$8,487 $31.09 p/Share	273 Reduced 1.08%	25,024 Common Stock

Also insider at

RFL

Rafael Holdings, Inc. Real Estate

Director

STK